A vascular 'fingerprint' on the light sensitive tissue layer at the back of the eye—the retina—can predict a person's risk of ...

Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...

Researchers at Oregon Health & Science University have uncovered how specialized cells surrounding small blood vessels, known ...

The book Tissue Engineering of Vascular Prosthetic Grafts, edited by Peter Zilla and Howard Greisler, explores the basic biology, clinical background and pathology of synthetic vascular graft ...

First human trials at Rutgers Health and other institutions demonstrate better infection resistance and limb preservation ...

SYMVESS is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial replacement and repair – – In clinical testing SYMVESS was ...

A vascular ‘fingerprint’ on the light sensitive tissue layer at the back of the eye-he retina-can predict a person’s risk of ...

The U.S. Food and Drug Administration has approved Symvess, the first acellular tissue engineered vessel indicated fo ...

There is a considerable clinical need for alternatives to the autologous vein and artery tissues used for vascular reconstructive surgeries such as CABG, lower limb bypass, arteriovenous shunts ...

The first acellular tissue engineered vessel for adults with vascular trauma in a bodily extremity has been approved by the U.S. FDA. Symvess, which comes from regenerative tissue developer Humacyte ...